Can the ankle brachial pressure index (ABPI) and carotis intima media thickness (CIMT) be new early stage markers of subclinical atherosclerosis in patients with rheumatoid arthritis?

Wiener Klinische Wochenschrift

Volumn 127, Issue 13-14, 2015, Pages 529-534

  Kurt, Tolga ^a   Temiz, Ahmet ^a   Gokmen, Ferhat ^a   Adam, Gurhan ^a   Ozcan, Sedat ^a   Ozbudak, Ersan ^b   Sacar, Mustafa ^a  

^a ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

^b KOCAELI UNIVERSITY   (Turkey)

Author keywords

Ankle brachial index; Carotid intima media thickness; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ADULT; ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE DURATION; DISEASE MARKER; FEMALE; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; RHEUMATOID ARTHRITIS; SYSTOLIC BLOOD PRESSURE; ARTHRITIS, RHEUMATOID; ASYMPTOMATIC DISEASE; COMORBIDITY; INCIDENCE; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA; TURKEY;

ANKLE BRACHIAL INDEX; ARTHRITIS, RHEUMATOID; ASYMPTOMATIC DISEASES; ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; CAUSALITY; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TURKEY;

EID: 84938291184     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-015-0767-x     Document Type: Article

References (29)

1. Pieringer H, Pichler M, Pohanka E, Hoppe UC. Will antirheumatic treatment improve cardiovascular outcomes in patients with rheumatoid arthritis? Curr Pharm Des. 2014;20(4):486–95.
2. Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59:1690–7.
3. Bacon PA, Stevens RJ, Carruthers DM, Young SP, et al. Accelerated atherogenesis in autoimmune rheumatic diseases. Autoimmun Rev. 2002;1(6):338–47.
4. Evans MR, Escalante A, Battafarano DF, et al. Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis. Arthritis Rheum. 2011;63(5):1211–20.
5. Farragher TM, Goodson NJ, Naseem H, et al. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum. 2008;58(2):359–69.
6. Sohaib A, Swati G, Minakshi D. Predictors of atherosclerosis in rheumatoid arthritis. Vasa. 2012;41:353–59.
7. Mookadam F, Moustafa SE, Lester SJ, et al. Subclinical atherosclerosis: evolving role of carotid intima media thickness. Prev Cardiol. 2010;13:186–97.
8. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, et al. ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010;56(25):e50–103. doi:10.1016/j.jacc.2010.09.001.
9. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21(2):93–111; quiz 189–90. doi:10.1016/j.echo.2007.11.011.
10. Heald CL, Fowkes FG, Murray GD, et al. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis. 2006;189(1):61–9.
11. Del Rincón I, O’Leary DH, Haas RW, et al. Effect of glucocorticoids on the arteries in rheumatoid arthritis. Arthritis Rheum. 2004;50:3813–22.
12. Kerekes G, Soltész P, Nurmohamed MT, Gonzalez-Gay MA, et al. Validated methods for assessment of subclinical atherosclerosis in rheumatology. Nat Rev Rheumatol. 2012;8(4):224–34. doi:10.1038/nrrheum.2012.16.
13. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
14. Bartels CM, Johnson H, Voelker K et al. Impact of rheumatoid arthritis on receiving a diagnosis of hypertension among patients with regular primary care. Arthritis Care Res (Hoboken). 2014. doi:10.1002/acr.22302.
15. Garza-García C, Rocío SS, Orea-Tejeda A, et al. Risk factors for asymptomatic ventricular dysfunction in rheumatoid arthritis patients. Cardiol. 2013;2013:635439. doi:10.1155/2013/635439 (eCollection 2013).
16. Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum. 2005;35:8–17.
17. Gonzalez-Juanatey C, Llorca J, Testa A, et al. Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore). 2003;82(6):407–13.
18. Criqui MH, Fronek A, Connor EB, et al. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71:510–15.
19. Van Sijl AM, Peters MJ, Knol DK, et al. Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. Semin Arthritis Rheum. 2011;40(5):389–97.
20. Society of Atherosclerosis Imaging and Prevention Developed in collaboration with the International Atherosclerosis Society. Appropriate use criteria for carotid intima media thickness testing. Atherosclerosis. 2011;214(1):43–6.
21. Mohan A, Sada S, Kumar BS, et al. Subclinical atherosclerosis in patients with rheumatoid arthritis by utilizing carotid intima-media thickness as a surrogate marker. Indian J Med Res. 2014;140(3):379–86.
22. López-Mejías R, Genre F, García-Bermúdez M, et al. The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima-media thickness in patients with rheumatoid arthritis. Arthritis Res Ther. 2013;15(5):R152.
23. López-Mejías R, Genre F, Corrales A. Investigation of a PON1 gene polymorphism (rs662 polymorphism) as predictor of subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis. 2014;73:1749–50. doi:10.1136/annrheumdis-2014-205543.
24. Del Rincon I, Haas RW, Pogosian S, et al. Lower limb arterial incompressibility and obstruction in rheumatoid arthritis. Ann Rheum Dis. 2005;64:425–32.
25. Guellec D, Bressollette L, Gueguen F, et al. Is routine ankle-brachial pressure index evaluation useful in rheumatoid arthritis? Joint Bone Spine. 2013;80(1):111–3
26. Ristic´ GG, Lepic´ T, Glisic´ B, et al. Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment. Rheumatology (Oxford). 2010;49(6):1076–81.
27. Kumeda Y, Inaba M, Goto H, et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum. 2002;46(6):1489–97.
28. Daza L, Aguirre M, Jimenez M, et al. Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors. Clin Rheumatol. 2007;26(4):533–7.
29. Corrales A, Parra JA, Juanatey CG, et al. Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis. 2013;72:1764–70. doi:10.1136/annrheumdis-2013-203688.